Technology being transferred to M/s Divine Meditech

India is among the top countries that reports the highest number of cervical cancer cases every year. Colposcopy is a medical procedure which needs to be carried out to diagnose cervix conditions and also to diagnose cervical cancer. Colposcope is an instrument that allows gynaecologists to perform colposcopy procedures. India imports a huge number of colposcope devices every year from different western countries.

The CSIR-CEERI team has now developed an indigenous IoT-enabled handheld colposcope system for cervix condition analysis and also for cervical cancer screening under the Make in India medical mission project sponsored by CSIR.  The developed colposcope system is cost-effective and has state-of-the-art features like connectivity to a smartphone-based app for quick data visualisation and analysis, cloud connectivity for direct communication between patients and doctors, software-based decision support to predict cervical cancer and on-device rechargeable battery support for continuous operation in rural camps. The developed system has been deployed at various hospitals for intensive testing and validation purpose.

The technology has been commercialised to M/s Divine Meditech, Noida on7  October 2022 for mass production and also for launching this technology in the Indian market. The company will bring the indigenous Make in India technology into the market in the next 3-6 months.